CTKB logo

Cytek Biosciences (CTKB) Company Overview

Profile

Full Name:

Cytek Biosciences, Inc.

Sector:

Healthcare

Country:

United States

IPO:

July 23, 2021

Indexes:

Not included

Description:

Cytek Biosciences (CTKB) specializes in advanced flow cytometry technology. They develop innovative tools and solutions for cell analysis, helping researchers in life sciences and clinical applications. Their products enhance the understanding of cell biology, enabling better disease diagnosis and treatment.

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Feb 27, 2025

Recent annual earnings:

Feb 27, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 4, 25 Piper Sandler
Overweight
Nov 11, 24 Piper Sandler
Overweight
Aug 13, 24 Piper Sandler
Overweight
May 13, 24 Piper Sandler
Overweight
Mar 6, 24 Piper Sandler
Overweight
Feb 29, 24 Goldman Sachs
Buy
Dec 14, 23 Stephens & Co.
Overweight
Nov 9, 23 Morgan Stanley
Equal-Weight
Oct 24, 23 Morgan Stanley
Equal-Weight
Oct 16, 23 Piper Sandler
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Cytek Biosciences?
  • Does Cytek Biosciences pay dividends?
  • What sector is Cytek Biosciences in?
  • What industry is Cytek Biosciences in?
  • What country is Cytek Biosciences based in?
  • When did Cytek Biosciences go public?
  • Is Cytek Biosciences in the S&P 500?
  • Is Cytek Biosciences in the NASDAQ 100?
  • Is Cytek Biosciences in the Dow Jones?
  • When was Cytek Biosciences's last earnings report?
  • When does Cytek Biosciences report earnings?
  • Should I buy Cytek Biosciences stock now?

What is the ticker symbol for Cytek Biosciences?

The ticker symbol for Cytek Biosciences is NASDAQ:CTKB

Does Cytek Biosciences pay dividends?

No, Cytek Biosciences does not pay dividends

What sector is Cytek Biosciences in?

Cytek Biosciences is in the Healthcare sector

What industry is Cytek Biosciences in?

Cytek Biosciences is in the Medical Devices industry

What country is Cytek Biosciences based in?

Cytek Biosciences is headquartered in United States

When did Cytek Biosciences go public?

Cytek Biosciences's initial public offering (IPO) was on July 23, 2021

Is Cytek Biosciences in the S&P 500?

No, Cytek Biosciences is not included in the S&P 500 index

Is Cytek Biosciences in the NASDAQ 100?

No, Cytek Biosciences is not included in the NASDAQ 100 index

Is Cytek Biosciences in the Dow Jones?

No, Cytek Biosciences is not included in the Dow Jones index

When was Cytek Biosciences's last earnings report?

Cytek Biosciences's most recent earnings report was on Feb 27, 2025

When does Cytek Biosciences report earnings?

The next expected earnings date for Cytek Biosciences is May 8, 2025

Should I buy Cytek Biosciences stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions